A potential new treatment for rare blood cancer was discovered by a team of researchers from University of British Columbia. We`re talking about the PNH (paroxysmal nocturnal hemoglobinemia), the rare type of blood cancer. The results of this study are published in PLOS ONE. The study was led by Prof. Patrick McGeer.
“Our study suggests that ATA could offer more complete protection as an oral treatment for PNH while eliminating the need for infusions”, said Prof. McGeer, professor emeritus in UBC's Department of Psychiatry. “PNH is a disease that may happen to anyone through a chance mutation, and if nature were to design a perfect fix for this mutation, it would be ATA”.
McGeer considers that this new treatment method could be efficient for treating diseases, such as Alzheimer`s disease or Parkinson`s disease, multiple sclerosis, rheumatoid arthritis, macular degeneration and ALS. The team is still testing the new treatment method.